The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra, who will soon ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

The high cost of living is a continuing burden for working families in Pueblo and across Colorado. A federal program intended ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

A Virginia House committee on Tuesday advanced a bipartisan proposal to create a Prescription Drug Affordability Board, ...

A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.

The Federal Trade Commission said in its second interim staff report on prescription-drug middlemen that the "significant markups" in prices above what the drugs cost generated an extra $7.3 billion ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...